O ciclo de valor e o preço dos medicamentos

Translated title of the contribution: Value cycle and pricing of pharmaceuticals

Maria da Conceição Constantino Portela

Research output: Contribution to journalArticlepeer-review



From access to term of marketing, medicines go through value cycles measured by the performance of endogenous and exogenous variables. Marketing access includes efficacy, safety profile, and therapeutic indications, whereas term of marketing comprises drug life cycle and public health priorities. The value cycles are time intervals during which the value is constant. The setting of the price of pharmaceuticals should occur according to the value observed in each cycle. A system of pricing based on value cycles is dynamic, transparent, and geared towards efficiency and sustainability. Agreement as a regulatory tool of administrative and legal relationship with the marketing authorization holder is committed to the goals of the health care system.
Translated title of the contributionValue cycle and pricing of pharmaceuticals
Original languagePortuguese
Pages (from-to)235-241
Number of pages7
JournalCadernos Saúde Coletiva
Issue number2
Publication statusPublished - 7 Jul 2016


  • Drug price
  • Government financing
  • Health expenditure


Dive into the research topics of 'Value cycle and pricing of pharmaceuticals'. Together they form a unique fingerprint.

Cite this